<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="EUR" hierarchy="1" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="http://iatistandard.org/203/schema/downloads/iati-activities-schema.xsd">
  <iati-identifier>NL-KVK-41207989-P-11108-2012023 - 2S4KN</iati-identifier>
  <reporting-org ref="NL-KVK-41207989" type="21">
   <narrative xml:lang="EN">Aidsfonds - Soaaids Nederland</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Research on retina and cognitive disorders in HIV-positive people</narrative>
  </title>
  <description type="4">
   <narrative xml:lang="EN">Despite the use of combination antiretroviral therapy (cART), cognitive impairment, classified as HIV Associated Neurocognitive Disorders (HAND), occurs in a substantial (15-60%) proportion of HIV patients. In addition to cognitive deficits, structural and functional abnormalities of the retina have been described in HIV-1-infected patients on cART without infectious retinitis. Thinning of the neuroretina has been demonstrated and corresponding subtle visual function loss develops, like loss of color vision and contrast sensitivity.</narrative>
  </description>
  <description type="1">
   <narrative xml:lang="EN">There are signs that people living with HIV are developing ageing-relating disorders at a younger age, such as forgetfulness or a retina condition. This research project aims to determine whether HIV-positive people with a retina disorder are at a higher risk of developing cognitive disorders and other brain conditions. If so, a simple eye examination can then be designed to conclude whether a person is in the risk group and requires extra monitoring.</narrative>
  </description>
  <description type="2">
   <narrative xml:lang="EN">This project aims to to assess the association between cognitive impairment and subtle brain and eye alterations in HIV-1-infected patients with sustained viral suppression on cART compared to HIV-negative controls of the same age.  
This study, baseline examination, follow-up examination after 2 years, and analysis of data of 125 subjects, can be performed in 3 years and will provide insight into the pathophysiology of neurocognitive disorders (HAND) in HIV positive patients by determining the value of a range of ophthalmologic, neuro-imaging and cerebrospinal fluid (CSF) parameters to serve as biomarkers of cerebral dysfunction and predictors of cognitive and visual impairment in HIV-1-infected patients. 
This would help to identify people that might develop HAND.

This project is integrated in the COBRA study and the AGEhiv study</narrative>
  </description>
  <description type="3">
   <narrative xml:lang="EN">people living with HIV
scientific community</narrative>
  </description>
  <participating-org ref="NL-KVK-41207989" role="1" type="22">
   <narrative xml:lang="EN">Aidsfonds Grants</narrative>
  </participating-org>
  <participating-org ref="NL-KVK-41207989" role="2" type="22">
   <narrative xml:lang="EN">Aidsfonds</narrative>
  </participating-org>
  <activity-status code="4"></activity-status>
  <activity-date iso-date="2012-07-31" type="1"></activity-date>
  <activity-date iso-date="2016-04-30" type="3"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">Aidsfonds - Soaaids Nederland</narrative>
   </organisation>
   <telephone>+31(0)206262669</telephone>
   <email>IATI@aidsfonds.nl</email>
  </contact-info>
  <recipient-country code="NL" percentage="100"></recipient-country>
  <sector code="13040" percentage="100" vocabulary="1">
   <narrative xml:lang="EN">Research on retina and cognitive disorders in HIV-positive people STD control including HIV/AIDS</narrative>
  </sector>
  <sector code="13040" percentage="100" vocabulary="1">
   <narrative xml:lang="EN">Research on retina and cognitive disorders in HIV-positive people STD control including HIV/AIDS</narrative>
  </sector>
  <policy-marker code="9" significance="1" vocabulary="1"></policy-marker>
  <collaboration-type code="3"></collaboration-type>
  <default-flow-type code="30"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget status="1" type="1">
   <period-start iso-date="2012-07-31"></period-start>
   <period-end iso-date="2016-04-30"></period-end>
   <value currency="EUR" value-date="2012-07-31">249959</value>
  </budget>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2015-12-30"></transaction-date>
   <value currency="EUR" value-date="2015-12-30">199964</value>
   <description>
    <narrative xml:lang="EN">1490 DOSS 2012023, CD301002</narrative>
   </description>
   <provider-org ref="NL-KVK-41207989">
    <narrative xml:lang="EN">Aidsfonds Grants</narrative>
   </provider-org>
   <receiver-org ref="NL-KVK-34362777">
    <narrative xml:lang="EN">AMC - Ophthalmology</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2015-12-30"></transaction-date>
   <value currency="EUR" value-date="2015-12-30">199964</value>
   <description>
    <narrative xml:lang="EN">1490 DOSS 2012023, CD301002</narrative>
   </description>
   <provider-org ref="NL-KVK-41207989">
    <narrative xml:lang="EN">Aidsfonds Grants</narrative>
   </provider-org>
   <receiver-org ref="NL-KVK-34362777">
    <narrative xml:lang="EN">AMC - Ophthalmology</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2016-12-28"></transaction-date>
   <value currency="EUR" value-date="2016-12-28">46296</value>
   <description>
    <narrative xml:lang="EN">1490 DOSS 2012023, CD301002</narrative>
   </description>
   <provider-org ref="NL-KVK-41207989">
    <narrative xml:lang="EN">Aidsfonds Grants</narrative>
   </provider-org>
   <receiver-org ref="NL-KVK-34362777">
    <narrative xml:lang="EN">AMC - Ophthalmology</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2016-12-28"></transaction-date>
   <value currency="EUR" value-date="2016-12-28">46296</value>
   <provider-org ref="NL-KVK-41207989">
    <narrative xml:lang="EN">Aidsfonds Grants</narrative>
   </provider-org>
   <receiver-org ref="NL-KVK-34362777">
    <narrative xml:lang="EN">AMC - Ophthalmology</narrative>
   </receiver-org>
  </transaction>
 </iati-activity>
</iati-activities>
